The vaccine maker, which has partnered with OpenAI since 2023, is rethinking how it does workforce planning thanks to the ...

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

What Happened? A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5% ...

We recently published a list of Billionaire David E. Shaw’s 10 Small-Cap Stock Picks with Huge Upside Potential. In this ...

Moderna is being audited by the PMCPA after yet again being found to have brought discredit on the pharma industry, putting ...

MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...

Key Takeaways Moderna's combo shot for flu and COVID-19 showed strong antibody responsesThe U.S. Food and Drug Administration ...

In a study published in the Journal of the American Medical Association, researchers from Moderna reported that the new combo ...

Moderna MRNA kicked off 2025 with mixed first-quarter results. While its streamlining efforts improved bottom-line numbers, the steep decline in revenues raises concerns. While sales of its COVID ...

The Trump administration stopped the study. Researchers from vaccine-maker Moderna reported in a study published Wednesday that the new combo shot generated a stronger immune response against ...

Researchers from vaccine-maker Moderna reported in a study published Wednesday that the new combo shot generated a stronger immune response against COVID-19 and most strains of flu than existing ...